Rett Syndrome Research Trust

About Rett Syndrome Research Trust

Founded in 2008 by Monica Coenraads, the Rett Syndrome Research Trust (RSRT) is dedicated to curing Rett syndrome, a rare genetic disorder linked to the MECP2 gene. With a focus on advancing genetic medicines, RSRT collaborates with scientists and biopharmaceutical companies to develop effective treatments.

Impact of RSRT

RSRT has funded numerous research initiatives that have significantly advanced the understanding and treatment of Rett syndrome. Their commitment has catalyzed the development of gene therapy programs currently in clinical trials.

Why Donate?

Your donations to RSRT fuel critical research aimed at curing Rett syndrome and related MECP2 disorders. Contributions directly support the development of genetic medicines and advance clinical trials, making a tangible difference in the lives of those affected.

Get Involved

Join the fight against Rett syndrome by donating today. Your support can help turn groundbreaking research into viable treatments, providing hope for countless families. Whether through cryptocurrency or cash, every contribution counts!